(S)-10-Hydroxycamptothecin - CAS 19685-09-7
Catalog number: 19685-09-7
Category: Inhibitor
Not Intended for Therapeutic Use. For research use only.
Molecular Formula:
Molecular Weight:
10-Hydroxycamptothecin inhibits the growth of BT-20 and MDA-231 cell with IC50 of 34.3 nM and 7.27 nM, respectively, more potently than camptothecin (CPT) with IC50 of >500 nM.
Publictions citing BOC Sciences Products
  • >> More
1.Antitumor efficacy and intratumoral distribution of SN-38 from polymeric depots in brain tumor model.
Vejjasilpa K1, Nasongkla N2, Manaspon C1, Larbcharoensub N3, Boongird A4, Hongeng S5, Israsena N6. Exp Biol Med (Maywood). 2015 Dec;240(12):1640-7. doi: 10.1177/1535370215590819. Epub 2015 Jun 16.
We investigate antitumor efficacy and 2D and 3D intratumoral distribution of 7-ethyl-10-hydroxycamptothecin (SN-38) from polymeric depots inside U-87MG xenograft tumor model in nude mice. Results showed that polymeric depots could be used to administer and controlled release of a large amount of SN-38 directly to the brain tumor model. SN-38 released from depots suppressed tumor growth, where the extent of suppression greatly depended on doses and the number of depot injections. Tumor suppression of SN-38 from depots was three-fold higher in animals which received double injections of depots at high dose (9.7 mg of SN-38) compared to single injection (2.2 mg). H&E staining of tumor sections showed that the area of tumor cell death/survival of the former group was two-fold higher than those of the latter group. Fluorescence imaging based on self-fluorescent property of SN-38 was used to evaluate the intratumoral distribution of this drug compared to histological results.
2.Nanomicelle Based Peroral Delivery System for Enhanced Absorption and Sustained Release of 10-Hydrocamptothecin.
Tian Y, Shi C, Zhang X, Sun Y, Wang J, Zhang Y, Yang J, Wang L, Wang L, Mao S. J Biomed Nanotechnol. 2015 Feb;11(2):262-73.
An effective sustained-release peroral drug delivery system is needed for chemotherapy. Here, we show that such a system can be achieved by designing polymeric nanomicelles combining mucoadhesion, enhanced absorption and controlled release. Chitosan and glyceryl-monooleate have many desirable properties, so we synthesized a novel chitosan derivative, chitosan-conjugated glyceryl monooleate. We loaded 10-hydroxycamptothecin (HCPT) into the cores of nanomicelles by pH-coacervation, which significantly improved drug loading and stability. We studied the pharmacokinetics of these drug-loaded nanomicelles, and they demonstrated remarkably prolonged circulation time in vivo up to 72 h. Orally administered HCPT-loaded nanomicelles also showed comparable antitumor effects and smaller changes in body weight compared to HCPT administered by injection. Most importantly, by using in vivo pharmacokinetic and pharmacodynamic studies, we showed that comparable antitumor effects can be achieved by peroral administration of HCPT-loaded nanomicelles every three days, and that the nanomicelles had less severe side effects.
3.Amphiphilic drugs as surfactants to fabricate excipient-free stable nanodispersions of hydrophobic drugs for cancer chemotherapy.
Hu S1, Lee E2, Wang C3, Wang J1, Zhou Z1, Li Y2, Li X3, Tang J1, Lee DH2, Liu X1, Shen Y4. J Control Release. 2015 Dec 28;220(Pt A):175-9. doi: 10.1016/j.jconrel.2015.10.031. Epub 2015 Oct 19.
Nanoformulations have been extensively explored to deliver water-insoluble drugs, but they generally use exotic new materials, for instance, amphiphilic block copolymers, which must first go through extensively clinical trials and be approved as drug excipients before any clinical uses. We hypothesize that using clinical amphiphilic drugs as surfactants to self-assemble with and thus solubilize hydrophobic drugs will lead to readily translational nanoformulations as they contain no new excipients. Herein, we show the first example of such excipient-free nanodispersions using an amphiphilic anti-tumor drug, irinotecan hydrochloride (CPT11). CPT11 self-assembles with its insoluble active parent drug, 7-ethyl-10-hydroxy camptothecin (SN38), into stable and water-dispersible nanoparticles, increasing SN38's water solubility by thousands of times up to 25 mg/mL with a loading efficiency close to 100%. The versatility of this approach is also demonstrated by fabricating nanodispersions of CPT11 with other water-insoluble drugs including paclitaxel (PTX) and camptothecin (CPT).
4.Nanodrug Formed by Coassembly of Dual Anticancer Drugs to Inhibit Cancer Cell Drug Resistance.
Zhao Y1, Chen F1,2, Pan Y1, Li Z1, Xue X1,2, Okeke CI1,2, Wang Y1,2, Li C1, Peng L3, Wang PC4, Ma X1, Liang XJ1. ACS Appl Mater Interfaces. 2015 Sep 2;7(34):19295-305. doi: 10.1021/acsami.5b05347. Epub 2015 Aug 19.
Carrier-free pure nanodrugs (PNDs) that are composed entirely of pharmaceutically active molecules are regarded as promising candidates to be the next generation of drug formulations and are mainly formulated from supramolecular self-assembly of drug molecules. It benefits from the efficient use of drug compounds with poor aqueous solubility and takes advantage of nanoscale drug delivery systems. Here, a type of all-in-one nanoparticle consisting of multiple drugs with enhanced synergistic antiproliferation efficiency against drug-resistant cancer cells has been created. To nanoparticulate the anticancer drugs, 10-hydroxycamptothecin (HCPT) and doxorubicin (DOX) were chosen as a typical model. The resulting HD nanoparticles (HD NPs) were formulated by a "green" and convenient self-assembling method, and the water-solubility of 10-hydroxycamptothecin (HCPT) was improved 50-fold after nanosizing by coassembly with DOX. The formation process was studied by observing the morphological changes at various reaction times and molar ratios of DOX to HCPT.
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related Products

CAS 82-98-4 Piperidolate

(CAS: 82-98-4)

Piperidolate is a tertiary amine antimuscarinic. It is similar to atropine. It is mainly used in the smooth muscle spasm of the gastrointestinal tract and inhib...

CAS 2415-24-9 Catalpol

(CAS: 2415-24-9)

Catalpol can be extracted from the herb of Rehmannia glutinosa (Gaert.) Libosch. ex Fisch. et Mey. It primary function is to stimulate the production of adrenal...

CAS 31112-62-6 Metrizamide

(CAS: 31112-62-6)

Metrizamide is a X-ray contrast agent related to Metrizoic Acid, used as a diagnostic aid (radiopaque medium).

CAS 682741-29-3 HTS01037

(CAS: 682741-29-3)

HTS01037, a high-affinity ligand of adipocyte fatty acid binding protein (A-FABP/aP2) (Ki = 0.67 μM), and is a competitive antagonist of protein-protein interac...

CAS 155683-00-4 Notoginsenoside Ft1

Notoginsenoside Ft1
(CAS: 155683-00-4)

Notoginsenoside Ft1, a new saponin solated from the leaves of P. notoginseng, as a stimulator of angiogenesis it is more potent compared with other bioactive sa...

Cgp 38560
(CAS: 122088-76-0)

Cgp 38560 is a potent renin inhibitor and it can induce a dose-dependent decrease in angiotensin II and plasma renin activity and a long-lasting and dose-depend...

(CAS: 872719-49-8)

TAK-683 is an investigational peptide derivative of metastin under the development of Millennium. It is a KISS1R protein agonist. Phase I development for prosta...

CAS 16208-51-8 Dimesna

(CAS: 16208-51-8)

Dimesna is a synthetic derivative of dithio-ethane sulfonate with uroprotective properties. In the kidney, dimesna undergoes reduction to the free thiol compoun...

(CAS: 179054-51-4)

FR-182980, a pyridine derivative, has been found to be a sterol O-acyltransferase inhibitor and was once studied in hypercholesterolaemia.

CAS 30751-05-4 Troxipide

(CAS: 30751-05-4)

Troxipide is a novel systemic non-antisecretory gastric cytoprotective agent with anti-ulcer, anti-inflammatory and mucus secreting properties irrespective of p...

CAS 6899-04-3 DL-Glutamine

(CAS: 6899-04-3)

DL-Glutamine is an unnatural amino acid and could be used for general biochemical research and drug synthesis.

CAS 345909-26-4 Taurocholic Acid Sodium Salt Hydrate

Taurocholic Acid Sodium Salt Hydrate
(CAS: 345909-26-4)

Choleretic; Its sodium salt is a bile salt formed in the liver by conjugation of cholic acid with taurine that is involved in the emulsification of lipids used ...

CAS 1260075-17-9 PKR-IN-1

(CAS: 1260075-17-9)

Activator of pyruvate kinase isoenzyme M2 (PKM2), an enzyme involved in glycolysis. Since all tumor cells exclusively express the embryonic M2 isoform of PK, it...

CAS 138844-81-2 Ibandronate Sodium

Ibandronate Sodium
(CAS: 138844-81-2)

Ibandronate sodium is a potent bisphosphonate drug developed by Hoffman La Roche and used in the prevention and treatment of osteoporosis and metastasis-associa...

CAS 179105-67-0 (Z)-MDL 105519

(Z)-MDL 105519
(CAS: 179105-67-0)

(Z)-MDL 105519 is the inactive isoform of MDL 105519 which is a high affinity NMDA glutamate receptor antagonist at the glycine site.

(CAS: 1213269-98-7)

This active molecular has a para-benzoquinone structure and was developed for inherited mitochondrial diseases base on vitamin E. The mechanism of action of Vat...

CAS 16320-04-0 Gestrinone

(CAS: 16320-04-0)

Gestrinone, also called as R2323, is a synthetic steroid hormone occasionally used to treat endometriosis and it inhibits leiomyoma cells (IC50= 43.67 μM).

CAS 33620-72-3 Britannilactone

(CAS: 33620-72-3)

A bioassay-guided isolation of the chloroform fraction of the I. britannica using an in vitro melanogenesis inhibition assay led to the isolation of sesquiterpe...

CAS 28860-95-9 Carbidopa

(CAS: 28860-95-9)

Carbidopa is an aromatic-L-amino-acid decarboxylase inhibitor with an IC50 of 29 ± 2 μM.

CAS 37517-30-9 Acebutolol

(CAS: 37517-30-9)

Acebutolol is a synthetic butyranilide derivative with hypotensive and antiarrhythmic activity as a beta blocker for the treatment of hypertension and arrhythmi...

Chemical Structure

CAS 19685-09-7 (S)-10-Hydroxycamptothecin

Quick Inquiry

Verification code

Featured Items